What Researchers Did
The authors wrote a guideline-style overview of interstitial cystitis, which they describe as a chronic pain syndrome, and reviewed the treatments that have been tried for it.
What They Found
This clinical guideline overview concludes that interstitial cystitis is a chronic pain syndrome rather than a disease of the bladder alone, and that no evidence-based treatment algorithm or standard therapy exists. The cause is still unknown, so no treatment aimed at the cause is available. The abstract lists oral drugs with differing levels of evidence (amitriptylin, hydroxyzin, pentosan polysulfate). It also lists intravesical options (botulinum toxin A, dimethyl sulfoxide, heparin, glycosaminoglycan substitutes) and physical procedures. For physical procedures, it says that besides bladder distension, hyperbaric oxygen therapy shows efficacy. It does not give any numbers, pressures or session counts. Surgery is described as the last resort when conventional methods fail.
What This Means for Canadian Patients
For people with interstitial cystitis, this overview says treatment is not standardized and many approaches have been tried. It names hyperbaric oxygen therapy as one physical procedure that shows efficacy, but it gives no details on how it was given, how many patients were treated, or how large any effect was. Patients should talk with their urologist about which options fit their situation.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a background overview rather than a trial, and the abstract gives no data on hyperbaric oxygen therapy, so the strength of the evidence behind its statement of efficacy cannot be judged from the abstract.